Halotestin Alternatives Compared
| Halotestin (fluoxymesterone) | Keytruda (pembrolizumab) | Abemaciclib |
|
|---|
| Halotestin (fluoxymesterone) | Keytruda (pembrolizumab) | Abemaciclib |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Hypogonadism - Male, Delayed Puberty - Male, Postmenopausal Symptoms, Breast Cancer, Breast Cancer - Palliative. Halotestin may also be used for purposes not listed in this medication guide. View more |
Prescription only
Keytruda is an immunotherapy treatment called a checkpoint inhibitor that helps your immune system fight cancer and is used to treat many different types of cancer in adults and children including... View more |
Prescription only
Prescribed for Breast Cancer. Abemaciclib may also be used for purposes not listed in this medication guide. |
Related suggestions Breast Cancer
|
|||||||
| More about (fluoxymesterone) | More about Keytruda (pembrolizumab) | More about Abemaciclib | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Keytruda has an average rating of 4.8 out of 10 from a total of 244 ratings on Drugs.com. 40% of reviewers reported a positive effect, while 50% reported a negative effect. |
Abemaciclib has an average rating of 8.2 out of 10 from a total of 31 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 3% reported a negative effect. |
||||||||
| Drug Class | ||||||||||
| Side Effects | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Keytruda prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms Available | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
|
N/A |
N/A |
Verzenio | ||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||
|
2 hours |
624 hours |
24.8 hours |
||||||||
| CSA Schedule ** View glossary of terms | ||||||||||
|
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 87 drugs are known to interact with Halotestin:
|
A total of 407 drugs are known to interact with Keytruda:
|
A total of 344 drugs are known to interact with Abemaciclib:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
|
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||
|
N/A |
N/A |
|||||||||
| More Information | ||||||||||
| Patient resources | ||||||||||
|
N/A |
||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
|
||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.